Remove business financial-sector
article thumbnail

Impact of EU sustainability directive on supply chains

European Pharmaceutical Review

Eighty four percent of pharmaceutical and healthcare companies consider that the new EU Corporate Sustainability Due Diligence Directive (CSDDD) directive is an opportunity to “align human rights and environmental protection with their business objectives”, findings from a survey by supply chain specialist INVERTO has found.

article thumbnail

Is the pharmaceutical sector realising its potential for sustainable manufacturing?

European Pharmaceutical Review

Globally, the pharmaceutical sector emitted around 52 megatonnes of CO 2 in 2015, the most recent period for which detailed numbers are available. 1 That’s more than the automotive sector, which released 46.4 However, changing long-standing and proven approaches to new product development across a whole sector is no small task.

89
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Merck reports rise in group net sales in fiscal 2022

Pharmaceutical Technology

The growth in sales was driven by all regions and business sectors, particularly Life Science. to €10.38bn in its Life Science business during the year. During the year, the company noted that net sales of the Healthcare business increased by 10.6% Merck has reported an increase in group net sales by 12.9% organic rise.

98
article thumbnail

Innovation key for boosting UK biopharma competitiveness

European Pharmaceutical Review

New recommendations to boost the competitiveness in UK biopharma and Medtech sectors have been published by Imperial College London. The ‘Sectoral Systems of Innovation and the UK’s Competitiveness’ reports assess the value-added per capita of each sector and how they compare internationally.

article thumbnail

Healthcare’s digital transformation began within weeks of pandemic – report

pharmaphorum

This was comparable to other sectors such as financial services (32 days), technology businesses (33), manufacturing and automotive (33) and retail (31). in financial services companies, 44.2% 89% of UK business leaders report that COVID-19 accelerated their move to the cloud. in construction, 37.6% in logistics.

article thumbnail

Novavax is on thin ice, and the latest update isn’t exactly encouraging

STAT

That makes Bluebird’s income statement a clean proxy for the business of gene therapy — which means the company’s financial results over the next year will educate the whole industry on whether it’s possible to turn costly, one-time therapies into a sustainable enterprise.

Vaccines 118
article thumbnail

The benefits of being a family-run pharma company

pharmaphorum

The third generation of his family to hold a leadership role at Chiesi Group, Giacomo Chiesi reflects on the lessons he learned from his father and grandfather – and from his work as a former management consultant – about what it means to run a successful family business and its benefits.